Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paperTong‐Yuan Yang, Vibha Jawa, John Kamerud et al.|Molecular Therapy — Methods & Clinical Development|2022Cited by 113
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trialTimothy A. Yap, Lu Gan, Randy F. Sweis et al.|Nature Medicine|2026Cited by 2